Padcev 30 mg lyophilized powder for injection Images
Generic Name: enfortumab vedotin
This medication has been identified as Padcev 30 mg lyophilized powder for injection. It is supplied by Astellas Pharma US, Inc.
Padcev is used in the treatment of Urothelial Carcinoma; Bladder Cancer and belongs to the drug class miscellaneous antineoplastics. Padcev 30 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Padcev
- Generic Name
- enfortumab vedotin
- Strength
- 30 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Astellas Pharma US, Inc.
- National Drug Code (NDC)
- 51144-0030
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Bavencio
Bavencio (avelumab) is a cancer medicine that interferes with the growth and spread of cancer cells ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Mutamycin
Mutamycin is used for bladder cancer, pancreatic cancer, stomach cancer
Erdafitinib
Erdafitinib is used for bladder cancer, urothelial carcinoma
Avelumab
Avelumab is used for merkel cell carcinoma, renal cell carcinoma, urothelial carcinoma
More about Padcev (enfortumab vedotin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.